In a significant milestone for theoretical condensed matter physics, a research team at the Helmholtz-Zentrum Berlin (HZB) has demonstrated that…
Read More
The biggest problem with solid-state batteries may finally be solved
The global transition toward a carbon-neutral economy is fundamentally tied to the evolution of energy storage technology. From the smartphones…
Read More
New solid-state material converts sunlight into higher-energy UV light
In a breakthrough that challenges traditional thermodynamic intuition, researchers at Kyushu University have announced the development of a novel solid-state…
Read More
Breakthrough in Solid-State Battery Research Reveals How Lithium Dendrites Fracture Ceramic Electrolytes
The global transition toward renewable energy and the electrification of transport hinges on a singular, critical component: the battery. As…
Read More
Breakthrough in Molecular Engineering Enables Solid-State Conversion of Visible Sunlight into Ultraviolet Radiation
The fundamental laws of thermodynamics generally dictate that energy tends to dissipate and degrade, moving from a concentrated state to…
Read More
Kyushu University Researchers Develop Breakthrough Solid-State Material for Converting Visible Sunlight into Ultraviolet Light
Researchers at Kyushu University have announced a significant advancement in material science with the creation of a new solid-state molecular…
Read More
Jazz Pharmaceuticals and AbCellera Forge Strategic Alliance to Pioneer Novel T-cell Engaging Antibodies for Gastrointestinal and Solid Tumors
Jazz Pharmaceuticals and AbCellera have announced a significant preclinical research, option, and license agreement, poised to accelerate the discovery and…
Read More
FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors
The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
Navigating the Evolving Landscape of Oral Solid Dosage Development: A Framework for Enhanced Efficiency and Commercial Success
The pharmaceutical industry is witnessing a significant evolution in oral solid dosage (OSD) development, driven by an increasing demand for…
Read More
Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors
Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read More
